{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Immunology & Inflammation > PMX-53CAS：219639-75-5
Molecular Formula：C47H65N11O7
Molecular Weight：896.09
Storage：Powder:-20℃，1 year;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：Solid
Qty：
Size：
| CAS | 219639-75-5 |
| Name | PMX-53 |
| Molecular Formula | C47H65N11O7 |
| Molecular Weight | 896.09 |
| Solubility | Soluble in DMSO |
| Purity | ≥98% |
| Appearance | Solid |
| Storage | Powder:-20℃，1 year;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| SMILES | CC(=O)NC(CC1=CC=CC=C1)C(=O)NC2CCCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C3CCCN3C2=O)CC4CCCCC4)CC5=CNC6=CC=CC=C65)CCCN=C(N)N |
| InChIKey | YOKBGCTZYPOSQM-HPSWDUTRSA-N |
| InChI | InChI=1S/C47H65N11O7/c1-29(59)53-37(25-30-13-4-2-5-14-30)42(61)55-36-20-11-22-50-41(60)35(19-10-23-51-47(48)49)54-44(63)39(27-32-28-52-34-18-9-8-17-33(32)34)56-43(62)38(26-31-15-6-3-7-16-31)57-45(64)40-21-12-24-58(40)46(36)65/h2，4-5，8-9，13-14，17-18，28，31，35-40，52H，3，6-7，10-12，15-16，19-27H2，1H3，(H，50，60)(H，53，59)(H，54，63)(H，55，61)(H，56，62)(H，57，64)(H4，48，49，51)/t35-，36-，37-，38+，39-，40-/m0/s1 |
| PubChem CID | 6918468 |
| Target Point | Complement System(C5aR/CD88) |
| Passage | Immunology & Inflammation |
| Background | It is a potent complement C5a receptor (CD88) antagonist and a low affinity MrgX2 agonist. |
| Unit | Bottle |
| Specification | 5mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
